Targeted therapy for multiple myeloma

[1] Toxicity and efficacy of defined doses of CD4+ donor lymphocytes for treatment of relapse after allogeneic bone marrow transplant [J]. BLOOD, 1998, 91 (10) : 3671 - 3680

[2] ALYEA EP, CANC PRINCIPLES PRAC

[3] ALYEA EP, IN PRESS BLOOD

[4] ANDERSON K, IN PRESS AUTOLOGOUS

[5] ANDERSON KC, 1993, BLOOD, V82, P2568

[6] ANDERSON KC, 1989, BLOOD, V73, P1915

[7] ANDERSON KC, 2000, EUROPEAN HAEMATOLOGY, P42

[8] ROLE OF INTERLEUKIN-6 IN THE GROWTH OF MYELOMA-DERIVED CELL-LINES [J]. LEUKEMIA RESEARCH, 1992, 16 (10) : 951 - 959

[9] Bellamy WT, 1999, CANCER RES, V59, P728

[10] ONCOSTATIN-M INDUCES ASSOCIATION OF GRB2 WITH JANUS KINASE JAK2 IN MULTIPLE-MYELOMA CELLS [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (06) : 1801 - 1806

[1] Toxicity and efficacy of defined doses of CD4+ donor lymphocytes for treatment of relapse after allogeneic bone marrow transplant [J]. BLOOD, 1998, 91 (10) : 3671 - 3680

[2] ALYEA EP, CANC PRINCIPLES PRAC

[3] ALYEA EP, IN PRESS BLOOD

[4] ANDERSON K, IN PRESS AUTOLOGOUS

[5] ANDERSON KC, 1993, BLOOD, V82, P2568

[6] ANDERSON KC, 1989, BLOOD, V73, P1915

[7] ANDERSON KC, 2000, EUROPEAN HAEMATOLOGY, P42

[8] ROLE OF INTERLEUKIN-6 IN THE GROWTH OF MYELOMA-DERIVED CELL-LINES [J]. LEUKEMIA RESEARCH, 1992, 16 (10) : 951 - 959

[9] Bellamy WT, 1999, CANCER RES, V59, P728

[10] ONCOSTATIN-M INDUCES ASSOCIATION OF GRB2 WITH JANUS KINASE JAK2 IN MULTIPLE-MYELOMA CELLS [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (06) : 1801 - 1806